Dr. John Murray-Pryce brings 25 years of bringing innovative new medicines to patients and creating equity in clinical research
WILMINGTON, Del. and MALMO, Sweden, Sept. 13, 2024 /PRNewswire-PRWeb/ — Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is thrilled to announce the appointment of John Murray to its Advisory Board. With a distinguished career spanning key areas of drug development, John brings invaluable experience and a lifelong passion for bringing innovative therapies to market while improving the equity of clinical research access for all patients worldwide.
My decision to join the Trialbee team was an easy one. To be able to contribute directly to a fast-growing company that is transforming patient recruitment and is similarly committed to equity is extremely exciting.
John joins the Trialbee Advisory Board following nearly 20 years at AstraZeneca, where he held diverse leadership roles across Medicine Development, Clinical Supply Chain, R&D Digital Health, and most recently Digital Patient Recruitment. Prior to that, he spent five years in Technical Operations at Merck & Co. John has a strong educational background in chemical engineering and is a Visiting Lecturer at the University of Birmingham. This unique combination has provided him firsthand knowledge of what it takes to bring a drug to market – and what it takes to bring people to clinical trials.
His decision to join Trialbee is driven by three key factors:
Remarkable Global Team. In an industry devoted to connecting patients and their families to better health opportunities, it’s critical to have talented and passionate people managing your recruitment solutions. The experienced team at Trialbee has earned its reputation for white glove Precision Management and unparalleled global expertise – with meaningful internal values to be humble, kind, curious, and fun.Industry-leading Patient Recruitment Platform (PRP). The Honey Platform™ stands out for its ability to find patients from multiple sources, medically pre-qualify them, connect them seamlessly with sites, and manage their journey from interest through enrollment. He specifically notes Honey’s consumer-grade user interface and flexible integration capabilities making it such a powerful tool in the emerging PRP landscape.Swedish Culture. John’s admiration for the Swedish culture is characterized by its quality and democratic values across gender, racial, political, and all other boundaries. These cultural attributes permeate every customer engagement at Trialbee as the team collaborates with sponsors, CROs, and sites to bring more equitable access to clinical research opportunities, and eventually life-changing treatments, to all patients worldwide.
“I am passionate about equity in society,” said John. “My decision to join the Trialbee team was an easy one. To be able to contribute directly to a fast-growing company that is transforming patient recruitment and is similarly committed to equity is extremely exciting. Throughout my career at major global pharmaceutical companies, I’ve seen how impactful the right combination of technology, people and process can be. By joining at this pivotal time, I hope to offer insights and learnings that help this team thrive. I am also eager to learn from what my fellow members on this impressive board.”
John joins an Advisory Board with more than a dozen proven leaders in life sciences, headed by Craig Lipset, including representatives from Bristol Myers Squibb, AbbVie, Savvy Cooperative, Actigraph, WebMD, and many more (view full Advisory Board members).
“I’m humbled and proud to work with such wonderful people helping guide our strategy and direction as we transform the face of global patient recruitment, and we all do it because patients deserve more from clinical research,” said Matt Walz, Trialbee CEO. “John brings an incredible wealth of experience having seen so many sides of technology in drug development and primarily through the lens of major pharmaceutical companies who have the potential to make tremendous impact on health equity and access to new medicines. I’m inspired by the quality and passion of our Advisory Board and it’s only more impressive this morning with John Murray-Pryce joining the Trialbee mission to improve clinical research access for all.”
To take control of your global patient recruitment, visit www.trialbee.com.
About Trialbee
Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company’s vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment — providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on meeting patients where they are in the treatment journey. To take control of patient recruitment for your next study, visit trialbee.com and follow us on LinkedIn.
Media Contact
Kristopher Sarajian, Trialbee, 46 101 963 260, kristopher.sarajian@trialbee.com, https://www.trialbee.com
View original content:https://www.prweb.com/releases/trialbee-adds-industry-authority-john-murray-pryce-to-its-distinguished-advisory-board-302247276.html
SOURCE Trialbee
